Importantly, disrupting this feedback loop through pharmacological inhibition of PKM2 or specific ablation in microglia enhances cognitive function and reduces Aβ pathology, highlighting lactylation as a potential therapeutic target in AD [80]. Here, PKM is linked to Alzheimer disease.